1Simpson SA, Tait JF, Bush IE. Secretion of a salt-retaining hormone by the mammalian adrenal cortex. Lancet, 1952,263:226
2Corm JW. Presidential address. Part Ⅱ: Primary aldosteronism: A new clinical syndrome. J Lab Clin Med, 1955, 45:3
3Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg, 1964,107:159
4Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest, 1996,98:1063
5Fullerton MJ, Funder JW. Aldosterone and cardiac fibrosis: In vitro studies. Cardiovasc Res, 1994,28:1863
6Weber KT. Aldosterone in congestive heart failure. N Engl J Med,2001,345:1689
7Funder J. Mineralocorticoids and cardiac fibrosis: The decade in review.Clin Exp Pharmacol Physiol, 2001,28: 1002
8Rocha R, Chander PN, Zuckerman A, et al. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension,1999,33:232
9Brown NJ, Nakamura S, Ma L, et al. Aldosterone medulates plasminogen activator inhibitor- 1 and glomerulosclerosis in vivo. Kidney Int, 2000,58:1219
10Ikeda U, Kafe T, Nakayama I, et al. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta. Eur J Pharmacol, 1995,290:69
同被引文献3
1Floege J,Eitner F.Present and future therapy options in IgA-nephropathy[J].J Nephrol,2005,18(4):354-361.
2Bortolotto LA,Cesena FH,Jatene FB,et al.Malignant hypertension and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma[J].Arq Bras Cardiol,2003,81(1):97-100.
3Jones DB.Arterial and glomerular lesions associated with severe hypertension.Light and electron microscopic studies[J].Lab Invest,1974,31(4):303-313.
